GLP1R and pancreatic neoplasm: Person-Years Use and Pancreatic Cancer Incidence According to Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) or Basal Insulin Use by Year Since Diabetes Diagnosis, Among 543 595 Individuals With Incident Diabetesa